HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abnormalities suggestive of latent tuberculosis infection on chest radiography; how specific are they?

AbstractBACKGROUND:
Several radiological features have been reported in association with latent tuberculosis infection (LTBI) but it has not been studied which are specific. The aim of this study was to evaluate allegedly characteristic abnormalities on chest radiography (CXR) in patients with LTBI compared to uninfected controls.
METHODS:
From 236 patients tested with QuantiFERON-TB Gold In-Tube (QFT), the CXR was re-evaluated in a blinded fashion for fibrotic scarring, (non-)calcified nodules and pleural thickening. LTBI was defined as presence of a positive QFT result and/or positive tuberculin skin test result stratified by Bacille Calmette-Guérin-vaccination status.
RESULTS:
Any predefined abnormality of LTBI was observed in 116/236 (49.2%) patients, the frequency not being different between groups. However, the specificity for LTBI of a fibrotic scar ≥ 2 cm2 was 100% [95% CI: 92.0%-100%] and of a calcified nodule ≥1.5 mm was 95.7% [95% CI: 85.2%-99.5%]. The frequency of non-calcified nodules and pleural thickening did not differ between groups.
CONCLUSION:
Only a fibrotic scar ≥ 2 cm2 and/or a calcified nodule ≥1.5 mm were significantly associated with LTBI. This finding is clinically relevant mainly in patients who are at significant risk of TB reactivation and in whom indirect diagnostic tests may be unreliable.
AuthorsJonathan W Uzorka, Lucia J M Kroft, Jaap A Bakker, Erik W van Zwet, Erik Huisman, Corine Prins, Cornelis J van der Zwan, Tom H M Ottenhoff, Sandra M Arend
JournalJournal of clinical tuberculosis and other mycobacterial diseases (J Clin Tuberc Other Mycobact Dis) Vol. 15 Pg. 100089 (May 2019) ISSN: 2405-5794 [Electronic] England
PMID31720416 (Publication Type: Journal Article)
Copyright© 2019 The Authors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: